Variant position: 620 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 758 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Gorilla DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Rhesus macaque DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Chimpanzee DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Mouse DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Rat DLSNVQSKCGSKDNIKHVPG GGSVHIVYKPVDLSKVTSKCG
Bovine DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Goat DLSNVQSKCGSKDNIKHVPG GGSVQIVYKPVDLSKVTSKCG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 758 Microtubule-associated protein tau
592 – 622 Tau/MAP 2
561 – 685 Microtubule-binding domain
607 – 607 Not glycated
611 – 611 Not glycated
615 – 615 Not glycated
628 – 628 Not glycated
634 – 634 Not glycated
638 – 638 Not glycated
602 – 602 Phosphoserine; by PHK
607 – 607 N6-acetyllysine
610 – 610 Phosphoserine
615 – 615 N6-acetyllysine; alternate
622 – 622 Phosphoserine; by PHK
628 – 628 N6,N6-dimethyllysine; alternate
628 – 628 N6-acetyllysine; alternate
634 – 634 N6-acetyllysine; alternate
638 – 638 N6-acetyllysine; alternate
608 – 639
615 – 615 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
628 – 628 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); in PHF-tau
634 – 634 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
638 – 638 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
592 – 622 Missing. In isoform Tau-A, isoform Tau-B, isoform Tau-C and isoform Fetal-tau.
618 – 620
A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.
Ros R.; Thobois S.; Streichenberger N.; Kopp N.; Sanchez M.P.; Perez M.; Hoenicka J.; Avila J.; Honnorat J.; de Yebenes J.G.;
Arch. Neurol. 62:1444-1450(2005)
Cited for: VARIANT PSNP1 VAL-620;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.